934 Factors associated with acute response to treatment of severe hypertension in pregnancy

2021 ◽  
Vol 224 (2) ◽  
pp. S579-S580
Author(s):  
Samantha J. Mullan ◽  
Alexandra M. Edwards ◽  
Jennifer E. Powel ◽  
Samantha K. Ong ◽  
Xujia Li ◽  
...  
2020 ◽  
Vol 222 (1) ◽  
pp. S122
Author(s):  
Samantha J. Mullan ◽  
Jennifer E. Powel ◽  
Alexandra M. Edwards ◽  
Megan L. Lawlor ◽  
Samantha K. Ong ◽  
...  

2022 ◽  
Vol 226 (1) ◽  
pp. S739-S740
Author(s):  
Sumithra Jeganathan ◽  
Cara Staszewski ◽  
Virginia White ◽  
Julie Hemphill ◽  
Leigha Carryl ◽  
...  

2022 ◽  
Vol 226 (1) ◽  
pp. S282
Author(s):  
Allison M. Davis ◽  
Christina T. Blanchard ◽  
Akila Subramaniam ◽  
Rachel G. Sinkey ◽  
Alan T. Tita ◽  
...  

2019 ◽  
Vol 7 ◽  
pp. 205031211984370 ◽  
Author(s):  
Stephanie Braunthal ◽  
Andrei Brateanu

Hypertensive disorders of pregnancy, an umbrella term that includes preexisting and gestational hypertension, preeclampsia, and eclampsia, complicate up to 10% of pregnancies and represent a significant cause of maternal and perinatal morbidity and mortality. Despite the differences in guidelines, there appears to be consensus that severe hypertension and non-severe hypertension with evidence of end-organ damage need to be controlled; yet the ideal target ranges below 160/110 mmHg remain a source of debate. This review outlines the definition, pathophysiology, goals of therapy, and treatment agents used in hypertensive disorders of pregnancy.


BMJ ◽  
1966 ◽  
Vol 1 (5482) ◽  
pp. 274-276 ◽  
Author(s):  
P. Kincaid-Smith ◽  
M. Bullen ◽  
J. Mills

Sign in / Sign up

Export Citation Format

Share Document